Vedolizumab and new‐onset spondyloarthritis: Debunking the myth
Published version
Peer-reviewed
Repository URI
Repository DOI
Change log
Authors
Description
Publication status: Published
Keywords
extra‐intestinal manifestations, adverse effects, treatment, inflammatory bowel disease
